Synairgen Share Discussion Threads

[gottopickapocketortwo] 20/7/2020 10:45

All over sky news

[grafter] 20/7/2020 10:43

Tiny U.K. Company’s Drug Cuts Covid-19 Risk
Shares of Synairgen Plc, a tiny pharmaceutical firm born out of a U.K. university, soared after the company said its experimental drug cut the risk of developing the worst symptoms of Covid-19.

“Valuing the Covid-19 opportunity is nigh on impossible,” FinnCap analyst Mark Brewer said in a note to clients, adding that upcoming discussions with regulators should clarify SNG001’s route to market. Finncap is also corporate broker to the company.

Synairgen, founded by three professors from the University of Southampton, previously partnered with AstraZeneca -

Bloomberg

[shirley83] 20/7/2020 10:36

Will see what the Americans think

[threadworm] 20/7/2020 10:36

Many congrats to all SNG holders - especially those who held on through the recent turbulence. Terrific rise and indeed, perhaps more to come?

You will each and all have your own plans as to how play this one over the coming minutes, hours, days and weeks. To add, sell, topslice etc.

No one size fits all.

So this is not at all a loaded ramp or deramp or indeed a tip....but instead just a 'heads up':

Put 4D Pharma (DDDD) on your watch lists.

It's not a pure Covid play, but has Covid exposure with a expedited phase 2 trial in full swing, plus major trial updates due within the next 6 months on a range of other indications including IBS, Asthma and Oncology. The latter is potentially the most significant. (ADYOR as ever).

SNG is clearly a class act and may well go considerably higher from here.....so each reach your own conclusions / decisions and best of luck.

[74tom] 20/7/2020 10:36

Only 150m shares in issue, that's enough for 15k investors to hold an average of 10k shares each... nothing at all.

As per the below article from The Times, this is by far the most promising drug WORLDWIDE, pending peer reviews etc.



"Synairgen, the pharmaceutical company developing the drug, is obliged by stock market rules to report preliminary results. If confirmed the findings would represent a dramatic breakthrough, adding to the small stock of drugs able to change the course of the disease."


"Until now only remdesivir, an anti-viral, and dexamethasone, a steroid, have been shown to have a clinical effect. The effectiveness of remdesivir was relatively low, merely lessening the time people spent in hospital, while dexamethasone was only useful in a subset of patients."

[shrewd_n_sharp] 20/7/2020 10:29

Heavy buying on Friday before the results? I reckon the FCA will look into that. Clearly it looks to me like someone is trading off the clinical trial test results. Or purely co-incidence!

[tidy 2] 20/7/2020 10:29

Agreed. Forget vaccines SNG001 is effective for all respiratory problems.

[yet another final] 20/7/2020 10:29

Still have to complete home trial If it showed that it saved lives, which such a small study could not, then the study would/may be terminated

[74tom] 20/7/2020 10:26

"It also showed that patients who received SNG001 were at least twice as likely to recover to the point where their everyday activities were not compromised through having been infected by SARS-CoV-2."

That is absolutely massive too, genuinely incredible news!

[d1nga] 20/7/2020 10:25

If you're unlucky enough to have contracted cv19 you will now be demanding to be on the trial or be given the treatment

[waterloo01] 20/7/2020 10:24

We might find out at 12.30. I do have a question about the ethics of still having a placebo. Guess that will be up to the regulator but whatever, recruitment won't be much of an issue.

[boothy2003] 20/7/2020 10:21

What happens with the home trial now? Seems wrong to still be giving patients the chance of receiving a placebo after these results